In its downstream pathway, GSF can not only inhibit insulin resistance induced by inflammatory cytokines but can also regulate glucose and lipid metabolism by directly or indirectly increasing IRS-1 activity (Figure 5D). The gene discussed is IRS1; the disease is Insulin resistance.